Product Information
EMGALITY 120 MG/ML PEN is a brand product labeled by Eli Lilly and Company, priced at $734.4146 per ML under NDC 00002143611. Its NADAC has been published 388 times since Jan 23, 2019.
Strength
120 mg/mL
Manufacturer
Eli Lilly and CompanyNDC
00002143611
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GALCANEZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761063On Market Since
9/27/2018
Price Statistics
The NADAC for EMGALITY 120 MG/ML PEN has been published 388 times since Jan 23, 2019, and over the history we have for it it has risen 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $734.4146 per ML |
|---|---|
| All-time high | $735.2057 (May 13, 2026) |
| All-time low | $553.6108 (Jan 23, 2019) |
| 52-week high | $735.2057 |
| 52-week low | $713.6881 |
| Median price | $631.9719 |
| Average price | $639.1279 |
| Largest weekly change | +5.0% (Jan 8, 2025) |
| Weeks tracked | 388 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMGALITY 120 MG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for EMGALITY 120 MG/ML PEN, manufactured by Eli Lilly and Company, is $734.4146 per ML (NDC 00002143611), effective Jun 24, 2026.
How has the price of EMGALITY 120 MG/ML PEN changed over time?
Over the history we have for it, the NADAC for EMGALITY 120 MG/ML PEN has risen 32.7%. It has been tracked across 388 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for EMGALITY 120 MG/ML PEN?
Since Jan 23, 2019, the NADAC for EMGALITY 120 MG/ML PEN has ranged from a low of $553.6108 (Jan 23, 2019) to a high of $735.2057 (May 13, 2026), with a median of $631.9719 per ML.
Are there cheaper alternatives to EMGALITY 120 MG/ML PEN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, EMGALITY 120 MG/ML SYRINGE, is $734.0275 per ML — about 0% below EMGALITY 120 MG/ML PEN.
Who manufactures EMGALITY 120 MG/ML PEN?
EMGALITY 120 MG/ML PEN (NDC 00002143611) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification